Latest Earnings Results: Q2 '26
Estimated EPS
-$0.46
Reported EPS
-$0.47
Surprise
-1.76%
Estimated Rev
$92.77M
Reported Rev
$94.5M
Surprise
+1.86%
• Reported GAAP EPS of -$0.47 down -34.29% YoY • Reported revenue of $94.5M up 19.34% YoY • PROCEPT BioRobotics reiterates full year 2026 revenue guidance of $390 million to $410 million, while expecting U.S. procedure volume of 54,000-56,000 and an adjusted EBITDA loss of $35 million to $30 million.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.39 | -- | -- | N/A |
Q2 '26 | -$0.46 | -$0.47 | -1.76% | MISSED |
Q1 '26 | -$0.56 | -$0.56 | 0.52% | BEAT |
Q4 '25 | -$0.32 | -$0.53 | -63.58% | MISSED |
Q3 '25 | -$0.41 | -$0.38 | 7.88% | BEAT |